Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Accumulated Expenses (2016 - 2024)

Creative Medical Technology Holdings has reported Accumulated Expenses over the past 9 years, most recently at $39920.0 for Q4 2024.

  • Quarterly Accumulated Expenses changed 0.0% to $39920.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $39920.0 through Dec 2024, changed 0.0% year-over-year, with the annual reading at $39920.0 for FY2024, 0.0% changed from the prior year.
  • Accumulated Expenses was $39920.0 for Q4 2024 at Creative Medical Technology Holdings, down from $42920.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $200000.0 in Q3 2020 and troughed at $24385.0 in Q4 2021.
  • The 5-year median for Accumulated Expenses is $39920.0 (2022), against an average of $68049.8.
  • Biggest five-year swings in Accumulated Expenses: soared 206.4% in 2020 and later crashed 85.04% in 2021.
  • Tracing CELZ's Accumulated Expenses over 5 years: stood at $159771.0 in 2020, then crashed by 84.74% to $24385.0 in 2021, then surged by 63.71% to $39920.0 in 2022, then changed by 0.0% to $39920.0 in 2023, then changed by 0.0% to $39920.0 in 2024.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $39920.0, $42920.0, and $39920.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.